Healthcare Cloud Computing Market is estimated to Witness High Growth Owing to Increased Adoption of Cloud-Based Services



Healthcare cloud computing refers to the on-demand delivery of computing resources and data storage services through the internet on a pay-as-you-go pricing model. This allows healthcare organizations to access and store patient records, imaging data, and other healthcare services remotely.

Market Dynamics:

Growing need to reduce healthcare IT costs and focus on core competencies in the healthcare industry is expected to drive the healthcare cloud computing market growth over the forecast period. Cloud computing offers healthcare organizations pay-as-you-go pricing model which helps eliminate upfront hardware and software costs. This lowers the overall IT expenses and improve operational efficiency. Furthermore, increasing adoption of electronic health records (EHR) and other healthcare IT solutions across providers is another factor augmenting the market growth. As per the Health IT Dashboard 2022, around 96% of hospitals and over 84% of office-based physicians have adopted certified health IT.

Two Major Market Drivers for Healthcare Cloud Computing

Increasing Need to Reduce Healthcare Costs Through Improved Efficiency

Adoption of cloud computing technologies allows healthcare organizations to move from expensive on-premise systems and data centers to more cost effective cloud based models. This enables organizations to reduce IT infrastructure and maintenance costs significantly. Cloud services also promote collaboration between different stakeholders such as payers, providers and patients. This level of collaboration and data sharing improves overall operational efficiency in the healthcare sector.

Growing Focus on Improving Patient Outcomes Through Better Access to Data and Services

Cloud platforms provide secure access to patient health records and clinical applications from anywhere. This empowers patients to take more control of their health and wellness. It also enables doctors and care teams to offer 24/7 access to services. Medical staff can easily collaborate across different locations to deliver better coordinated care. Additionally, cloud based storage and analytics of large healthcare datasets is improving research outcomes and accelerating discovery of new treatments.

One Major Market Restrain for Healthcare Cloud Computing

Concerns Around Data Security, Privacy and Compliance with Regulations

Despite the benefits, healthcare organizations remain wary of moving sensitive patient data to public cloud environments due to security and privacy risks. Patient health records contain highly confidential information and any leak could severely damage their trust in healthcare providers. Moreover, the healthcare industry operates under stringent regulations around data protection, privacy and compliance like HIPAA in the US. Ensuring that cloud platforms and service providers meet these compliance standards is a challenge slowing down adoption. Additionally, keeping unauthorized access to cloud hosted systems and preventing data breaches requires robust security controls and continuous monitoring. Addressing these security and regulatory compliance concerns is crucial for the market to realize its full potential.

One Major Market Opportunity for Healthcare Cloud Computing

Growing Telehealth and Remote Patient Monitoring Services

The Covid-19 pandemic has boosted the demand for telehealth and virtual healthcare delivery models. Cloud platforms play a critical role in powering these remote services through secure access to clinical applications, real-time communications and storage/analysis of patient health data collected outside hospitals and clinics. This represents a significant growth opportunity for healthcare cloud providers to partner with telehealth startup and equip doctors and nurses to seamlessly offer virtual consultations, monitor patients externally and deliver hospital level care in home setting as well. As advanced technologies like 5Gnetworking and IoT medical devices become mainstream, cloud based telehealth market is expected to grow rapidly in the coming years.

One Major Market Trend for Healthcare Cloud Computing

Increasing Adoption of AI and Analytics in Cloud based Healthcare Applications

Cloud platforms are enabling wider use of AI, machine learning and advanced analytics across variety of healthcare domains including drug discovery, genomics, clinical decision support, medical imaging and population health management. Cloud giants are partnering with leading AI and analytics companies to develop specialized tools and datasets for the life sciences industry. This offers new opportunities for AI and analytics in healthcare like improving diagnostic accuracy, detecting diseases early, personalized treatment recommendations and optimizing clinical trial processes. The combined capabilities of cloud, AI and analytics holds promise to dramatically transform healthcare and deliver step change improvements in outcomes at lower costs. Their adoption will largely define healthcare IT landscape in the coming decade.

Comments

Post a Comment

Popular posts from this blog

Fibrinolytic Therapy is Anticipated to Witness Moderate Growth Owing to Rising Prevalence of Cardiovascular Diseases

Image
The global fibrinolytic therapy market is estimated to be valued at US$ 34.96 Bn in 2024 and is expected to exhibit a CAGR of 3.7% over the forecast period of 2023 to 2030. Fibrinolytic therapy, also called thrombolysis, involves the use of clot-busting drugs to dissolve blood clots and restore blood flow. Rising prevalence of cardiovascular diseases such as heart attacks and strokes has increased the demand for fibrinolytic drugs worldwide. Fibrinolytic therapy improves patient outcomes and recovery rates by dissolving the clots blocking arteries and restoring blood flow to tissues and organs. Key players operating in the fibrinolytic therapy market are Genentech, Inc. (Roche), Bayer AG, Boehringer Ingelheim International GmbH, Pfizer Inc., Bristol Myers Squibb Company, Novartis AG, AstraZeneca PLC, Johnson & Johnson, Daiichi Sankyo Company, Limited, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Mitsub...
Read more

Intraocular Lens Market to Witness High Growth Due to Rising Prevalence of Cataract Across Globe

Image
Intraocular lens (IOL) is an artificial lens which is implanted inside eyes during cataract surgery to replace clouded eye lenses. IOL helps enhance vision and provides independence from glasses or contact lenses by helping patients restore clarity of vision. IOLs act as replacement for eye's natural crystalline lens after cataract removal. The global intraocular lens market is mainly driven by rising geriatric population suffering from age-related cataracts across the globe. Cataract is common age-related eye disease, affecting vision and quality of life of elderly people. As per the World Health Organization (WHO), cataracts are the leading cause of blindness globally affecting over 38 million population worldwide. Growing cases of cataract and demand for its minimally invasive surgeries are propelling market growth. The Global intraocular lens market is estimated to be valued at US$ 5,076.1 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to ...
Read more

Exploring the Frontiers of Healthcare: In Vitro Diagnostics (IVD)

Image
  In today's era of cutting-edge medical technology, the field of diagnostics plays a pivotal role in healthcare. Among the various diagnostic methods available, in vitro diagnostics (IVD) stands out as a cornerstone of modern medicine. IVD encompasses a wide range of tests performed on bodily fluids or tissue samples outside the body, providing valuable insights into a patient's health status and aiding in the diagnosis, treatment, and monitoring of diseases. From routine screenings to complex molecular analyses, IVD has revolutionized medical practice, paving the way for personalized and precise healthcare interventions. Understanding In Vitro Diagnostics : In vitro, Latin for "in glass," denotes tests conducted in a controlled laboratory setting, outside the living organism. In the context of diagnostics, this involves analyzing biological specimens such as blood, urine, saliva, and tissue samples collected from patients. IVD techniques utilize various analytical m...
Read more